UNSPSC 51373448: Codeine/papaverine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373448 Codeine/papaverine is a Commodity code that covers controlled pharmaceutical substances and related parenteral products actually being procured by state and local corrections and public health agencies. The scope extends beyond the code name alone to encompass parenteral nutrition solutions, intravenous solutions, naloxone, and other controlled and non-controlled pharmaceutical products used in correctional healthcare, emergency response, and community health settings. Issuing bodies include state departments of corrections and county health authorities. The Washington State Department of Corrections is a repeat buyer, issuing an RFQ for parenteral products, services, and equipment across eight correctional facilities in September 2026 with a due date of October 7, 2026. This procurement emphasizes set-asides and preferences for small businesses (25%), minority-owned businesses (10%), women-owned businesses (6%), and veteran-owned businesses (5%) under state-level utilization requirements. Bidders must demonstrate experience preparing and delivering IV and parenteral nutrition solutions with rapid turnaround — parenteral nutrition bags within 24 hours and other products within 8 hours — and must carry substantial insurance including Commercial General Liability, Professional Liability, Business Automobile Liability, and Cyber Liability coverage.

Recent activity concentrates in Washington and Florida. The Washington State Department of Corrections RFQ covers three regions across the state (West, Central, and East) with an anticipated contract term from November 26, 2026 through June 30, 2030 and discretionary extension rights, with pricing fixed for the first two years. Seminole County, Florida issued an IFB in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, though the cited due date of July 26, 2023 appears erroneous in the source. Both opportunities require E-Verify compliance and drug-free workplace certification. Vendors must be Washington State business licensed and pass Washington State Patrol NCIC clearance for the Department of Corrections contract; the Seminole County contract is potentially FEMA-funded and includes adherence to federal environmental regulations.